Showing results (1281-1290 of 5,724) with videos related to

Sort By:
Pageof 573
Medical Oncology (Northwood, London, England)|January 22, 2024
Chitosan-loaded piperlongumine nanoparticles and kaempferol enhance the anti-cancer action of doxorubicin in targeting of Ehrlich solid adenocarcinoma: in vivo and in silico modeling studyFawziya A R Ibrahim, Neveen A Hussein, Aisha Y M Soliman, et al.
Medical Oncology (Northwood, London, England)|December 8, 2023
Moving beyond cisplatin resistance: mechanisms, challenges, and prospects for overcoming recurrence in clinical cancer therapyRui Fu, Borui Zhao, Min Chen, et al.
Medical Oncology (Northwood, London, England)|December 9, 2023
Upregulation of CELSR1 expression promotes ovarian cancer cell proliferation, migration, and invasionJiwei Zuo, Anqi Zheng, Xingyue Wang, et al.
Medical Oncology (Northwood, London, England)|March 13, 2024
Role of interferon-induced transmembrane protein family in cancer progression: a special focus on pancreatic cancerPeipei Wang, Yan Pan, Yu Zhang, et al.
Medical Oncology (Northwood, London, England)|February 28, 2024
An effective treatment approach of liposomally encapsulated metformin in colon cancerEnis Cetin, Olcay Boyacioglu, Seda Orenay-Boyacioglu
Medical Oncology (Northwood, London, England)|February 11, 2024
Selective targeting or reprogramming of intra-tumoral TregsKeywan Mortezaee
Medical Oncology (Northwood, London, England)|April 4, 2024
Unlocking the potential: phenylboronic acid as a nuclear-targeting boron agent for neutron capture therapyJiejian Chen, Yonghao Li, Xiaoning Gan, et al.
Medical Oncology (Northwood, London, England)|April 9, 2024
Combination of IFN-gamma with STING agonist and PD-1 immune checkpoint blockade: a potential immunotherapy for gastric cancerShahnaz Hosseinzadeh, Mahsa Imani, Farhad Pourfarzi, et al.
Medical Oncology (Northwood, London, England)|April 11, 2024
A novel α,β-unsaturated ketone inhibits leukemia cell growth as PARP1 inhibitorWeijia Zhao, Min Mo, Jia Yu, et al.
Medical Oncology (Northwood, London, England)|February 23, 2024
Evaluation of TRIM63 RNA in situ hybridization (RNA-ISH) as a potential biomarker for alveolar soft-part sarcoma (ASPS)Alexander S Taylor, Rahul Mannan, Liron Pantanowitz, et al.
Pageof 573